个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

ALT flares were linked to HBsAg reduction, seroclearance and seroconversion: interim results from a phase IIb study in chronic hepatitis B patients with 24-week treatment of subcutaneous PD-L1 Ab ASC22 (Envafolimab) plus nucleos (t)ide analogs

| 认领 | 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE

作者：
Wang, Guiqiang[1] * ; Cui, Yimin[2] ; Xie, Yao[3] ; Mao, Qianguo[4] ; Xie, Qing[5] ; Gu, Ye[6] ; Chen, Xin-Yue[7] ; Hu, Guoxin[8] ; Yang, Yongfeng[9] ; Lu, Jiajie[10] ; Zou, Guizhou[11] ; Zhang, Qin[12] ; Fu, Lei[13] ; Chen, Yongping[14] ; Guo, Xiaolin[15] ; Hou, Jinlin[16] ; Yan, Yuemei[17] ; He, Handan[17] ; Wu, Jinzi[17] ;
机构： [1]Peking Univ First Hosp, Dept Infect Dis, Beijing, Peoples R China [2]Peking Univ First Hosp, Clin Trial Ctr, Beijing, Peoples R China [3]Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China [4]Xiamen Hosp Tradit Chinese Med, Xiamen, Peoples R China [5]Shanghai Jiao Tong Univ, Dept Infect Dis, Ruijin Hosp, Coll Med, Shanghai, Peoples R China [6]Shenyang Sixth Peoples Hosp, Shenyang, Peoples R China [7]Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China [8]Peking Univ, Shenzhen Hosp, Shenzhen, Peoples R China [9]Nanjing Second Hosp, Nanjing, Peoples R China [10]Sichuan Univ, West China Hosp, Chengdu, Peoples R China [11]Anhui Med Univ, Affiliated Hosp 2, Hefei, Peoples R China [12]Shanghai Tongren Hosp, Shanghai, Peoples R China [13]Cent South Univ, Xiangya Hosp, Changsha, Peoples R China [14]Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China [15]Jilin Univ, Hosp 1, Changchun, Peoples R China [16]Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China [17]Ascletis BioSci Co Ltd, Hangzhou, Peoples R China
出处：
ISSN：
语种：
外文
被引次数：
WOS：
中科院(CAS)分区：
出版当年[2021]版：
大类 | 1 区 医学
小类 | 1 区 胃肠肝病学
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 胃肠肝病学
JCR分区：
出版当年[2020]版：
Q1 GASTROENTEROLOGY & HEPATOLOGY
最新[2023]版：
Q1 GASTROENTEROLOGY & HEPATOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者：
第一作者机构： [1]Peking Univ First Hosp, Dept Infect Dis, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Wang Guiqiang,Cui Yimin,Xie Yao,et al.ALT flares were linked to HBsAg reduction, seroclearance and seroconversion: interim results from a phase IIb study in chronic hepatitis B patients with 24-week treatment of subcutaneous PD-L1 Ab ASC22 (Envafolimab) plus nucleos (t)ide analogs[J].JOURNAL OF HEPATOLOGY.2022,77:S70-S70.
APA：
Wang, Guiqiang,Cui, Yimin,Xie, Yao,Mao, Qianguo,Xie, Qing...&Wu, Jinzi.(2022).ALT flares were linked to HBsAg reduction, seroclearance and seroconversion: interim results from a phase IIb study in chronic hepatitis B patients with 24-week treatment of subcutaneous PD-L1 Ab ASC22 (Envafolimab) plus nucleos (t)ide analogs.JOURNAL OF HEPATOLOGY,77,
MLA：
Wang, Guiqiang,et al."ALT flares were linked to HBsAg reduction, seroclearance and seroconversion: interim results from a phase IIb study in chronic hepatitis B patients with 24-week treatment of subcutaneous PD-L1 Ab ASC22 (Envafolimab) plus nucleos (t)ide analogs".JOURNAL OF HEPATOLOGY 77.(2022):S70-S70

资源点击量：21169 今日访问量：0 总访问量：1219 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持：重庆聚合科技有限公司 地址：北京市东城区东交民巷1号(100730)